<DOC>
	<DOCNO>NCT02951650</DOCNO>
	<brief_summary>This open label multicenter study safety efficacy active implantable VNS device patient Crohn 's Disease .</brief_summary>
	<brief_title>Long Term Observational Study Vagal Nerve Stimulation Device Crohn 's Disease</brief_title>
	<detailed_description>Patients complete study SPM-007 enrol study time last visit precede study . The assessment last visit precede study also use baseline measure current study . If patient previously discontinue SPM-007 great 30 day elapse since final visit SPM-007 , baseline measure current study repeat , interim medical history take assess whether new medical condition diagnose time study . The study continue last patient enter complete 24 month study . Follow-up visit occur 3 , 6 , 12 , 18 24 month . A final follow-up visit occur remain patient study closure final enrol subject complete 24 month study . An Interim Visit must perform maximum 1 month change device setting . Interim visit may also perform time principal investigator 's discretion ; either schedule visit , patient complete Month 24 Visit , study still ongoing .</detailed_description>
	<mesh_term>Crohn Disease</mesh_term>
	<criteria>Patients must enrol study SPM007 ; include patient either complete study withdraw completion study . Inability provide inform consent Significant psychiatric illness substance abuse All patient exclude developed exclusionary condition SMP007 study , interim SPM007 Day 0 SPM010 : History unilateral bilateral vagotomy History recurrent vasovagal syncope episodes Known obstructive sleep apnea Known history cardiac rhythm disturbance , atrioventricular block great first degree , cardiac conduction pathway abnormality isolate right bundle branch block isolate leave anterior fascicle block . Significant pharyngeal dysfunction swallow difficulty Clinically significant vocal cord damage hoarseness Other implant electrically active medical device ( e.g. , cardiac pacemaker , automatic implantable cardioverterdefibrillators ) Asthma chronic obstructive pulmonary disease control medication , disease cause clinically significant dyspnea A great equal 40 packyear smoke history Active peptic ulcer disease Patients limit life expectancy due terminal illness</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>vagus nerve stimulation</keyword>
</DOC>